Halo Healthcare, Inc. Company Profile
Halo Healthcare is a diagnostic device company specializing in women’s breast health. The HALO® Breast Test is a 5-minute, non-invasive test that elicits NAF for subsequent cytopathology analysis to determine if there is the presence of abnormal cells from the breast ducts. The results of the HALO test help determine a woman’s risk of developing breast cancer so appropriate steps can be taken by her medical provider which could lead to early detection. The Company is researching other biomarkers present in NAF for the detection of cancer.
News Articles
HIPAA Compliant, Secure Texting App Doc Halo Lands Key Contract with Premier Healthcare Network
Cincinnati, Ohio (PRWEB) March 21, 2013 Doc Halo, the secure healthcare texting app that allows physicians and medical professionals to communicate within a HIPAA-compliant platform, has announced...
A women’s health care company in turnaround – one well recognized for assessing a woman’s risk of developing breast cancer through the HALO breast test – is developing a breast cancer diagnost...
Halo Healthcare, Inc., Makers of the HALO@ Breast Test for Risk Assessment and Early Detection of Breast Cancer, Announces New Organization IRVINE, Calif.--(BUSINESS WIRE)--May 23, 2012-- Halo Health...
Halo Healthcare acquires assets of NeoMatrix
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, an...
Teva Canada completes sale of Mirabel facility to Halo Pharmaceutical
Teva Canada, a healthcare solutions provider, has completed the sale of its Mirabel manufacturing facility in Montreal to Halo Pharmaceutical, a contract development and manufacturing organization (CD...
Halo seeks renewal as controlled substance producer; buys Teva plant
US CMO Halo Pharma has asked the Drug Enforcement Administration (DEA) to renew its registration as a manufacturer of controlled substances.
Cincinnati, OH, February 28, 2013 --(PR.com)-- Doc Halo’s co- founder and Chief Executive Officer Jose Barreau, MD has been named a "Health Care Hero" for 2013 by the Cincinnati Busin...
Halo Healthcare, University of North Dakota School of Medicine deal
Drugs and Medications
Christian dior prestige brightening revitalizing uv base spf 50 [Parfums Christian Dior]
Dior Prestige UV Base White Collection SPF 50
Cd dior prestige white collection satin brightening uv base spf 50 [Parfums Christian Dior]
CD Dior Prestige White Collection Satin Brightening UV Base SPF 50
Drug Facts
oxygen
Isagel [Coloplast Manufacturing US, LLC]
Isagel HandwashingNo-Rinse, Antiseptic Hand Cleansing Gel with Added Moisturizers
PubMed Articles
Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis.
Background  In analogy with melanoma-associated leucoderma, halo naevi may trigger in some patients the development of additional depigmentations which are in distribution, extent and prognosis not...
Upon treating transition-metal-dihaloboryl complexes of the form [L(n) MBX(2) ] with K[(η(5) -C(5) H(5) )MnH(CO)(2) ], salt elimination occurs along with a migration of the Mn-bound hydride ligand on...
Pin site allergic contact dermatitis: an unusual complication of halo fixation.
We report a case of halo pin site allergic contact dermatitis, a rare complication of halo vest immobilisation (HVI), necessitating device removal. Although uncommon, pin site allergic contact dermati...
The first regiocontrolled synthesis of procyanidin B6, a dimer with a rare 4,6-interflavan linkage, is described. Regioselective linking was achieved by the halo-capping strategy followed by removal o...
Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
Several 5-alkyl (or halo)-3'-azido (amino or halo) analogs of pyrimidine nucleosides have been synthesized and evaluated against Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium...
Clinical Trials
HALO Patient Registry: Ablation of Barrett's Esophagus
The HALO Patient Registry is a prospective/retrospective, multi-center patient registry. It provides a framework for treatment and follow-up of patients with Barrett's esophagus (non-dyspl...
Determining Optimal Halo Pin Management Practises to Decrease Pin Complications
The purpose of this study is to evaluate the effects of regular pin re-tensioning on pain, pin loosening and pin replacement.
Ubiquitous Healthcare for Elderly Patients With Type 2 Diabetes Mellitus
Ubiquitous healthcare service for elderly patients with type 2 diabetes provides real-time glycemic monitoring and glucose control implemented by clinical decision support system (CDSS) us...
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
Medical staff will be screened for MRSA and ESBL (including: doctors, nurses, nurse aids, physical therapists, dietitians, Janitors and other medical staff). PURPOSE: To define the...
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
The purpose of this study is to determine whether fish oil supplementation with Lovaza, formally known as Omacor will result in a significant reduction in serum triglyceride (TG), an incre...
Companies
Halo Healthcare is a diagnostic device company specializing in women’s breast health. The HALO® Breast Test is a 5-minute, non-invasive test that elicits NAF for subsequen...
Headquartered in Huntsville, Ala., Halo Monitoring is a user-centric healthcare technology company focused on improving the quality of life for aging seniors and their caregivers....
Halo Pharmaceutical, headquartered in Whippany, NJ, is a specialty pharmaceutical company engaged in pharmaceutical branded product lifecycle management. The company's strategy is to acquire products...
BARRX Medical, Inc. develops endoscopic treatment solutions for Barrett's esophagus and other chronic gastroenterological diseases. Barrett's is a precancerous condition of the lining of the esophagu...
HemoGenix® is a privately held company located in Colorado Springs, Colorado U.S.A. HemoGenix® was founded in March 2000 by Ivan N. Rich, PhD, an internationally recognized researcher in the field...
More Information about "Halo Healthcare, Inc." on BioPortfolio
We have published hundreds of Halo Healthcare, Inc. news stories on BioPortfolio along with dozens of Halo Healthcare, Inc. Clinical Trials and PubMed Articles about Halo Healthcare, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Halo Healthcare, Inc. Companies in our database. You can also find out about relevant Halo Healthcare, Inc. Drugs and Medications on this site too.
